IL53559A0 - Novel prostaglandin analogues their preparation and pharmaceutical compositions containing them - Google Patents

Novel prostaglandin analogues their preparation and pharmaceutical compositions containing them

Info

Publication number
IL53559A0
IL53559A0 IL53559A IL5355977A IL53559A0 IL 53559 A0 IL53559 A0 IL 53559A0 IL 53559 A IL53559 A IL 53559A IL 5355977 A IL5355977 A IL 5355977A IL 53559 A0 IL53559 A0 IL 53559A0
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
prostaglandin analogues
novel prostaglandin
Prior art date
Application number
IL53559A
Other languages
English (en)
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB52955/76A external-priority patent/GB1598662A/en
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of IL53559A0 publication Critical patent/IL53559A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C273/00—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C273/18—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas
    • C07C273/1809—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas with formation of the N-C(O)-N moiety
    • C07C273/1818—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas with formation of the N-C(O)-N moiety from -N=C=O and XNR'R"
    • C07C273/1827—X being H
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL53559A 1976-12-18 1977-12-07 Novel prostaglandin analogues their preparation and pharmaceutical compositions containing them IL53559A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB52955/76A GB1598662A (en) 1976-12-18 1976-12-18 10,12-diazoprostaglandins
GB3036977 1977-07-20

Publications (1)

Publication Number Publication Date
IL53559A0 true IL53559A0 (en) 1978-03-10

Family

ID=26260409

Family Applications (1)

Application Number Title Priority Date Filing Date
IL53559A IL53559A0 (en) 1976-12-18 1977-12-07 Novel prostaglandin analogues their preparation and pharmaceutical compositions containing them

Country Status (15)

Country Link
JP (1) JPS5382779A (de)
AT (1) AT368498B (de)
AU (1) AU514523B2 (de)
CH (1) CH639076A5 (de)
DE (1) DE2755771A1 (de)
DK (1) DK551777A (de)
ES (1) ES465176A1 (de)
FI (1) FI773812A7 (de)
FR (1) FR2374309A1 (de)
IL (1) IL53559A0 (de)
NL (1) NL7713971A (de)
NO (1) NO774348L (de)
NZ (1) NZ185909A (de)
PH (1) PH14398A (de)
SE (1) SE7714373L (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1602188A (en) 1977-12-01 1981-11-11 Wellcome Found Hydantoin derivatives
JPS5492962A (en) * 1977-12-01 1979-07-23 Wellcome Found Thiohydantoin compound
DE2963795D1 (en) * 1978-01-23 1982-11-11 Beecham Group Plc Hydantoins and thiohydantoins, method for their preparation and pharmaceutical compositions containing them
EP0004723A1 (de) * 1978-03-30 1979-10-17 Beecham Group Plc Deoxyhydantoine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
CA1122222A (en) * 1978-06-15 1982-04-20 Frederick Cassidy Novel 1,2,4-triazolidine-3,5-dione derivatives
IL57504A0 (en) * 1978-06-15 1979-10-31 Beecham Group Ltd Prostagandin analogues,their preparation and pharmaceutical compositions containing
AU4778279A (en) * 1978-06-15 1979-12-20 Beecham Group Limited Prostaglandin analogues
EP0006352A1 (de) * 1978-06-15 1980-01-09 Beecham Group Plc Hydantoine und Thiohydantoine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
GB2050371A (en) * 1979-05-09 1981-01-07 Wellcome Found Optically active hydantoin derivatives and pharmaceutical formulations containing them

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2323193A1 (de) 1972-05-10 1973-11-22 Du Pont Pyrazolidinone
FR2258376A1 (en) 1974-01-21 1975-08-18 Aries Robert 10-Aza prostaglandins - for treatment of blood pressure and gastro-intestinal disorders and in prepn for confinement
GB1524818A (en) 1974-11-29 1978-09-13 Beecham Group Ltd 12-azaprostaglandins

Also Published As

Publication number Publication date
FR2374309B1 (de) 1980-05-16
AT368498B (de) 1982-10-11
NL7713971A (nl) 1978-06-20
PH14398A (en) 1981-06-25
NZ185909A (en) 1980-11-14
AU514523B2 (en) 1981-02-12
FI773812A7 (fi) 1978-06-19
AU3161377A (en) 1979-06-21
CH639076A5 (en) 1983-10-31
NO774348L (no) 1978-06-20
JPS5382779A (en) 1978-07-21
DE2755771A1 (de) 1978-06-29
ATA893777A (de) 1982-02-15
ES465176A1 (es) 1979-01-01
FR2374309A1 (fr) 1978-07-13
DK551777A (da) 1978-06-19
SE7714373L (sv) 1978-06-19

Similar Documents

Publication Publication Date Title
IL51660A0 (en) Hentriakontapeptides their preparation and pharmaceutical compositions containing them
IL53043A0 (en) Novel 1-aryloxy-2-hydroxy-3-aminopropane - derivatives their preparation and pharmaceutical compositions containing them
IL51816A0 (en) Novel steroids their preparation and pharmaceutical compositions containing them
ZA771003B (en) Pharmaceutical compositions containing pyrethrinoides
NZ185884A (en) Derivatives of 1,2,3,4-tetrahydronaphthalene and pharmaceutical compositions containing them
IL53589A0 (en) Novel nucleosides their preparation and pharmaceutical compositions containing them
IL51301A0 (en) Novel oxygenated n-aryl-diazacyclic compounds their manufacture and pharmaceutical compositions containing them
IL49325A0 (en) Novel prostaglandin derivatives,their preparation and pharmaceutical compositions containing them
GB1544191A (en) Acylaminopiperidines processes for their preparation and pharmaceutical compositions containing them
IL51812A0 (en) New isothiazolopyridine derivatives their preparation and pharmaceutical compositions containing them
IL52137A0 (en) Novel aryltrifluoroethylamines their preparation and pharmaceutical compositions containing them
IL52615A (en) 1-aza-prostaglandin analogues,their preparation and pharmaceutical compositions containing them
IL52638A0 (en) Novel olivanic acid derivatives their preparation and pharmaceutical compositions containing them
IL53560A0 (en) Novel prostaglandin analogues their preparation and pharmaceutical compositions containing them
IL50644A (en) 12-aza-11-oxo-15-hydroxyprostanoic acid analogues,their preparation and pharmaceutical compositions containing them
IL52103A0 (en) Pharmaceutical compositions containing naphthopyrane derivvatives
IL56404A0 (en) Novel analogs of h-endorphin, their preparation and pharmaceutical compositions containing them
IL51468A0 (en) Novel d-homosteroids their preparation and pharmaceutical compositions containing them
IL53026A0 (en) New pyridobenzodiazepinones their preparation and pharmaceutical compositions containing them
IL53552A (en) 1-piperazinopropanol esters,their preparation and pharmaceutical compositions containing them
IL57504A0 (en) Prostagandin analogues,their preparation and pharmaceutical compositions containing
AU506442B2 (en) Prostaglandin analogues and pharmaceutical compositions
IL52006A0 (en) Novel nephthalene derivatives their preparation and pharmaceutical compositions containing them
IL53009A0 (en) New imidazoisoquinoline derivatives their preparation and pharmaceutical compositions containing them
IL52562A0 (en) Novel cyanoprostaglandins their preparation and pharmaceutical compositions containing them